PURE Bioscience, Inc. ( OTCQB: PURE ) (the “Company,” “PURE” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for...
CHICAGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- PureCircle and Almendra reached an amicable settlement in a patent dispute in the United States relating to Almendra’s Steviarome® products and use thereof....
PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today announced the appointment of Jason Kawata as its new Vice President of Technology,...
PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2020...
PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, has entered into a strategic alliance with Marathon Group, LLC and Whiting Systems,...
PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antiviral/antibacterial, and Packers Sanitation Services, Inc. (PSSI), have entered into an exclusive...